Kymera Therapeutics, Inc. Common Stock Share Price
NASDAQ: KYMRHealthcare
Live Kymera Therapeutics, Inc. Common Stock Share Price Chart
O H L
Kymera Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$117.48Low
$118.53High
Markets Today
| Previous Close | $118.48 |
|---|---|
| Open | $118.53 |
| Volume | 108,543 |
| Day's Range | $117.48 - $118.53 |
| 52W Range | $47.86 - $130.05 |
| Market Cap | $9.67 B |
Historical Performance
| 1M Returns | -2.39 |
|---|---|
| 3M Returns | +31.02 |
| 6M Returns | +49.71 |
| 1Y Returns | +131.59 |
| 5Y Returns | +88.21 |
| 10Y Returns | NA |
Kymera Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $9.67 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $39.21 M |
| ROE TTM | -0.26 |
| EPS TTM | $-3.24 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.38 |
| EBITDA | $-337.23 M |
| Profit Margin | -794.04 |
| Market Cap | $9.67 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $39.21 M |
| ROE TTM | -0.26 |
| EPS TTM | $-3.24 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.38 |
| EBITDA | $-337.23 M |
| Profit Margin | -794.04 |
Kymera Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $22.10 M | $11.48 M | $2.76 M | $2.87 M | $34.37 M | $65.00 M |
| Gross Profit + | $22.10 M | $11.48 M | $2.76 M | $2.87 M | $34.37 M | $65.00 M |
| Operating Income | -$74.50 M | -$84.56 M | -$92.52 M | -$97.90 M | -$84.22 M | -$75.61 M |
| EBITDA | -$72.45 M | -$82.47 M | -$86.52 M | -$95.86 M | -$82.19 M | -$73.58 M |
| Interest Expense | $0 | $8.05 M | -$98.00 K | $280.00 K | $0 | $14.48 M |
| Depreciation | $2.05 M | $2.08 M | $6.00 M | $2.03 M | $2.02 M | $2.03 M |
| Income Before Tax | -$65.58 M | -$76.61 M | -$82.17 M | -$86.98 M | -$69.23 M | -$61.21 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$65.58 M | -$76.61 M | -$82.17 M | -$86.98 M | -$69.23 M | -$61.21 M |
| Net Profit Margin | -296.75% | -667.6% | -2973.05% | -3030.7% | -201.47% | -94.17% |
Kymera Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $7.00 K | $7.00 K | $7.00 K | $8.00 K | $8.00 K | $8.00 K |
| Reserve & Surplus | -$820.25 M | -$896.53 M | -$977.48 M | -$1.06 B | -$1.14 B | -$1.20 B |
| Non-Current Liabilities | $73.09 M | $72.05 M | $84.21 M | $79.94 M | $66.74 M | $64.86 M |
| Current Liabilities | $58.99 M | $87.54 M | $71.58 M | $83.21 M | $62.64 M | $71.33 M |
| Total Liabilities | $132.08 M | $159.59 M | $155.79 M | $163.15 M | $129.38 M | $136.19 M |
| Fixed Assets | $49.17 M | $48.57 M | $45.13 M | $43.17 M | $41.62 M | $39.97 M |
| Current Assets | $500.95 M | $728.33 M | $528.30 M | $871.21 M | $677.43 M | $737.26 M |
| Total Assets | $918.31 M | $1.13 B | $1.10 B | $1.74 B | $1.67 B | $1.65 B |
Kymera Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$65.58 M | -$76.61 M | -$82.17 M | -$86.98 M | -$69.23 M | -$61.21 M |
| Operating Cash Flow | -$79.15 M | -$59.88 M | -$27.11 M | -$66.75 M | -$88.84 M | -$54.06 M |
| Investing Cash Flow | $48.62 M | $60.02 M | -$235.30 M | -$394.40 M | -$142.84 M | $20.05 M |
| Financing Cash Flow | $258.00 K | $245.73 M | $39.51 M | $705.22 M | $18.77 M | $14.42 M |
| Change in Cash | -$30.28 M | $245.86 M | -$222.90 M | $244.07 M | -$212.91 M | -$19.60 M |
Kymera Therapeutics, Inc. Common Stock Return Calculator
The Kymera Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$18,561
Invested Amount$10,000
Est. Returns$8,561
About Kymera Therapeutics, Inc. Common Stock
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
Popular Stocks
FAQs
What is the share price of Kymera Therapeutics, Inc. Common Stock today?
Kymera Therapeutics, Inc. Common Stock (KYMR) share price as of September 18, 2026 is $116.84. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Kymera Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Kymera Therapeutics, Inc. Common Stock (KYMR) Share by opening an international trading account with Angel One.
How can I purchase Kymera Therapeutics, Inc. Common Stock shares in India?
Purchasing Kymera Therapeutics, Inc. Common Stock (KYMR) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Kymera Therapeutics, Inc. Common Stock (KYMR) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Kymera Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Kymera Therapeutics, Inc. Common Stock (KYMR) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Kymera Therapeutics, Inc. Common Stock?
The market capitalization of Kymera Therapeutics, Inc. Common Stock on September 18, 2026, is $9.67 B.
In which sector Kymera Therapeutics, Inc. Common Stock belongs?
Kymera Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Kymera Therapeutics, Inc. Common Stock stocks?
In order to invest in Kymera Therapeutics, Inc. Common Stock (KYMR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
